summary: Extracorporeal photochemotherapy (ECP) is an immunomodulating procedure consisting of autologous reinfusion of peripheral blood mononuclear cells after direct exposure to 8-methoxy-psoralen and UV-A. This study confirms ECP safety and tolerability and suggests that this treatment might be useful as a therapeutic alternative in the subgroup of relapsing-remitting MS patients not responsive to or not eligible for traditional immunomodulating or immunosuppressive treatments.

authors: Cavaletti G, Perseghin P, Dassi M, Cavarretta R, Frigo M, Caputo D, Stanzani L, Tagliabue E, Zoia C, Grimaldi M, Isella V, Rota S, Ferrarese C, Frattola L.

source: Neurol Sci. 2006 Apr;27(1):24-32.

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: